Urinary tract obstruction, also known as obstructive uropathy, is a medical condition that affects the urinary system. It results from the blockage of urine flow, which can be caused by structural or functional abnormalities. The blockage leads to the backup of urine in the kidneys. Obstructive uropathy can occur unilaterally or bilaterally, depending on the location of the obstruction.
The symptoms of this condition can vary but typically involve difficulty initiating urination, acute urinary retention, lower abdominal discomfort, and distention. The severity of the symptoms depends on the degree and duration of the obstruction. Urinary tract obstruction can be acute or chronic and affect people of all ages and demographics. The condition can be caused by various factors, including urinary stones, tumors, prostate enlargement, congenital abnormalities, and trauma.
Epidemiology
Urinary obstruction can affect individuals of all age groups, but it is most commonly observed in two distinct populations, namely infants and the elderly. While congenital genitourinary tract abnormalities such as posterior urethral valves may cause urinary obstruction in children, they only represent around 4% of all cases.
On the other hand, most cases occur in individuals over 60, with males being more frequently affected due to the presence of the prostate gland, which may undergo benign prostatic hyperplasia or develop cancer. In men, symptoms of urinary retention resulting from BPH may arise in up to 2% of cases per year.
Obstructive uropathy is much less common in females. Nonetheless, other factors, such as pregnancy or childbirth, may increase the risk of urinary obstruction in women.
Anatomy
Pathophysiology
When there is an obstruction in the urinary tract, urine flow is restricted, causing urine to flow back into the kidney’s collecting system. Over time, this can lead to the expansion of the urinary tract and damage the kidney’s filtration system, resulting in obstructive nephropathy.
This condition can be caused by various factors, including increased pressure due to distention and decreased blood flow. In cases of partial obstruction, the body may attempt to alleviate the obstruction by increasing ureteral peristalsis. However, complete obstruction can lead to increased distention and intraluminal pressures, causing more damage.
Animal studies have shown the involvement of the renin-angiotensin-aldosterone system and increased expression of TGF-beta1 in hydronephrotic kidneys, which may also occur in humans. It is challenging to predict the rate and timing of kidney damage, underscoring the importance of early detection and treatment of the obstruction.
Etiology
Obstructive uropathy have multiple causes, with benign prostatic hypertrophy or hyperplasia being the most diagnosed. However, other possible causes include prostatic adenocarcinoma, urethral strictures, colonic endometriosis, phimosis or paraphimosis, retroperitoneal adenopathy, urolithiasis, ureterocele, neuropathic bladder dysfunction, bladder endometriosis, parasitic obstructions, and urate nephrolithiasis.
Accurate diagnosis of the underlying cause heavily relies on a thorough history and physical examination. Obstructive uropathy can also manifest during the neonatal period, indicating the need to assess genitourinary tract dilatation and vesicoureteral reflux and emphasize the importance of performing intrauterine fetal anatomy ultrasounds.
Genetics
Prognostic Factors
The prognosis of an obstruction largely depends on its underlying cause. If the obstruction is acute, it is more likely to be reversible and less harmful to kidney function. However, chronic obstruction can have long-term detrimental effects on renal function.
If only one kidney is affected initially, the likelihood of developing chronic renal problems is lower. Long-term management, such as hemodialysis or renal transplant, may be necessary in rare cases where renal dysfunction persists or worsens after acute obstruction. Neglecting to treat concurrent UTIs can also worsen the overall prognosis.
Clinical History
Clinical History
Urinary tract obstructions can cause a wide range of symptoms. The severity and symptoms depend on various factors, including the location and degree of obstruction and the time since onset. Pain is a common symptom associated with urinary tract obstructions, typically felt in the abdominal and flank region.
When assessing a patient with suspected urinary tract obstruction, healthcare providers may use the characteristics of the pain to help determine the underlying cause and location of the obstruction.
Other symptoms that may suggest a specific underlying cause of urinary tract obstruction include night sweats, unintentional weight loss, and hematuria with a nodular prostate on examination, which may indicate prostatic malignancy. Additionally, previous radiation therapy or other cancer treatments can lead to scarring in the urinary tract, which can also result in obstruction.
Physical Examination
Physical Examination
A comprehensive evaluation of the patient’s strength, sensation, reflexes, and muscle tone can provide valuable information for diagnosing urinary tract obstruction. Conducting a thorough medical history and physical examination can help identify the underlying cause of the condition. If a patient experiences symptoms such as nocturia, dysuria, urinary urgency or frequency, and decreased force of the urinary stream, it could be an indication of benign prostatic hyperplasia or prostatic adenocarcinoma.
Additionally, the presence of a fever could be a cause for concern for a concomitant urinary tract infection and, potentially, septicemia. In the case of a nodular prostate on examination, hematuria, and recent unintentional weight loss, it is important to consider the possibility of prostatic malignancy.
Patients experiencing gastrointestinal symptoms such as constipation, nausea, vomiting, and diarrhea could be diagnosed with fecal impaction, bowel obstruction, or a colonic mass, contributing to urinary tract obstruction. Moreover, patients who have had recent surgeries, such as appendectomy or hysterectomy, may have a ureteral injury that should be taken into consideration.
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Differential Diagnoses
Nephrolithiasis
Prostatitis
Tuberculosis
Spinal epidural abscess
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Correcting electrolyte abnormalities is necessary, and prompt action should be taken to address obstructive uropathy. Bladder volume measurements can aid in determining the appropriate course of treatment. In most cases, the first line of treatment is the use of a Foley catheter, particularly in cases where benign prostatic hypertrophy or hyperplasia is the cause of the obstruction. However, if obstruction persists, further interventions may be necessary.
In such cases, a Coudé tip Foley catheter may be used, or more significant interventions may be required. Medication therapies may also be considered in certain cases. Alpha-1-adrenergic receptor inhibitors such as terazosin and tamsulosin have been shown to improve symptoms of urinary obstruction in patients with BPH by relaxing the smooth muscles in the bladder and prostate. Studies have indicated that tamsulosin has a positive effect on moderate to severe obstructive symptoms due to BPH, with minimal side effects such as orthostasis.
Additionally, medications like leuprolide and bicalutamide, which act through antiandrogen and luteinizing hormone agonism, respectively, may be helpful in reducing obstruction by shrinking the prostate. Dutasteride and finasteride are approved by the FDA for the treatment of benign prostatic hyperplasia (BPH). These drugs work by inhibiting the 5-alpha-reductase enzyme, which is responsible for the conversion of testosterone to dihydrotestosterone (DHT). By blocking this conversion, they can help reduce the size of the prostate, which is often enlarged in BPH.
In cases of BPH, it is common for medical therapies to be combined in order to produce a more effective outcome. Combining different medications often produces a synergistic effect, which means that the overall effectiveness of the treatment is greater than the sum of its individual components. In cases where BPH has caused obstructive nephropathy, it is important to address the urinary tract obstruction to prevent further kidney damage.
The obstruction can often be relieved through medical or surgical interventions, depending on the severity and underlying cause. Once the obstruction has been relieved, medical therapies such as finasteride and dutasteride may be used to help reduce the size of the prostate and prevent further obstruction.
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Medication
Future Trends
Media Gallary
References
News
Rare Uterine Lipoma Diagnosed Post-Surgery: Case Report
Posted on
News
Robotic Breakthrough in Brain Surgery
Posted on
News
Bangladesh Achieves Remarkable Reduction in Lead in Turmeric
Posted on
News
Suppressing Negative Thoughts Can Improve Mental Health
Urinary tract obstruction, also known as obstructive uropathy, is a medical condition that affects the urinary system. It results from the blockage of urine flow, which can be caused by structural or functional abnormalities. The blockage leads to the backup of urine in the kidneys. Obstructive uropathy can occur unilaterally or bilaterally, depending on the location of the obstruction.
The symptoms of this condition can vary but typically involve difficulty initiating urination, acute urinary retention, lower abdominal discomfort, and distention. The severity of the symptoms depends on the degree and duration of the obstruction. Urinary tract obstruction can be acute or chronic and affect people of all ages and demographics. The condition can be caused by various factors, including urinary stones, tumors, prostate enlargement, congenital abnormalities, and trauma.
Urinary obstruction can affect individuals of all age groups, but it is most commonly observed in two distinct populations, namely infants and the elderly. While congenital genitourinary tract abnormalities such as posterior urethral valves may cause urinary obstruction in children, they only represent around 4% of all cases.
On the other hand, most cases occur in individuals over 60, with males being more frequently affected due to the presence of the prostate gland, which may undergo benign prostatic hyperplasia or develop cancer. In men, symptoms of urinary retention resulting from BPH may arise in up to 2% of cases per year.
Obstructive uropathy is much less common in females. Nonetheless, other factors, such as pregnancy or childbirth, may increase the risk of urinary obstruction in women.
When there is an obstruction in the urinary tract, urine flow is restricted, causing urine to flow back into the kidney’s collecting system. Over time, this can lead to the expansion of the urinary tract and damage the kidney’s filtration system, resulting in obstructive nephropathy.
This condition can be caused by various factors, including increased pressure due to distention and decreased blood flow. In cases of partial obstruction, the body may attempt to alleviate the obstruction by increasing ureteral peristalsis. However, complete obstruction can lead to increased distention and intraluminal pressures, causing more damage.
Animal studies have shown the involvement of the renin-angiotensin-aldosterone system and increased expression of TGF-beta1 in hydronephrotic kidneys, which may also occur in humans. It is challenging to predict the rate and timing of kidney damage, underscoring the importance of early detection and treatment of the obstruction.
Obstructive uropathy have multiple causes, with benign prostatic hypertrophy or hyperplasia being the most diagnosed. However, other possible causes include prostatic adenocarcinoma, urethral strictures, colonic endometriosis, phimosis or paraphimosis, retroperitoneal adenopathy, urolithiasis, ureterocele, neuropathic bladder dysfunction, bladder endometriosis, parasitic obstructions, and urate nephrolithiasis.
Accurate diagnosis of the underlying cause heavily relies on a thorough history and physical examination. Obstructive uropathy can also manifest during the neonatal period, indicating the need to assess genitourinary tract dilatation and vesicoureteral reflux and emphasize the importance of performing intrauterine fetal anatomy ultrasounds.
The prognosis of an obstruction largely depends on its underlying cause. If the obstruction is acute, it is more likely to be reversible and less harmful to kidney function. However, chronic obstruction can have long-term detrimental effects on renal function.
If only one kidney is affected initially, the likelihood of developing chronic renal problems is lower. Long-term management, such as hemodialysis or renal transplant, may be necessary in rare cases where renal dysfunction persists or worsens after acute obstruction. Neglecting to treat concurrent UTIs can also worsen the overall prognosis.
Clinical History
Urinary tract obstructions can cause a wide range of symptoms. The severity and symptoms depend on various factors, including the location and degree of obstruction and the time since onset. Pain is a common symptom associated with urinary tract obstructions, typically felt in the abdominal and flank region.
When assessing a patient with suspected urinary tract obstruction, healthcare providers may use the characteristics of the pain to help determine the underlying cause and location of the obstruction.
Other symptoms that may suggest a specific underlying cause of urinary tract obstruction include night sweats, unintentional weight loss, and hematuria with a nodular prostate on examination, which may indicate prostatic malignancy. Additionally, previous radiation therapy or other cancer treatments can lead to scarring in the urinary tract, which can also result in obstruction.
Physical Examination
A comprehensive evaluation of the patient’s strength, sensation, reflexes, and muscle tone can provide valuable information for diagnosing urinary tract obstruction. Conducting a thorough medical history and physical examination can help identify the underlying cause of the condition. If a patient experiences symptoms such as nocturia, dysuria, urinary urgency or frequency, and decreased force of the urinary stream, it could be an indication of benign prostatic hyperplasia or prostatic adenocarcinoma.
Additionally, the presence of a fever could be a cause for concern for a concomitant urinary tract infection and, potentially, septicemia. In the case of a nodular prostate on examination, hematuria, and recent unintentional weight loss, it is important to consider the possibility of prostatic malignancy.
Patients experiencing gastrointestinal symptoms such as constipation, nausea, vomiting, and diarrhea could be diagnosed with fecal impaction, bowel obstruction, or a colonic mass, contributing to urinary tract obstruction. Moreover, patients who have had recent surgeries, such as appendectomy or hysterectomy, may have a ureteral injury that should be taken into consideration.
Differential Diagnoses
Nephrolithiasis
Prostatitis
Tuberculosis
Spinal epidural abscess
Correcting electrolyte abnormalities is necessary, and prompt action should be taken to address obstructive uropathy. Bladder volume measurements can aid in determining the appropriate course of treatment. In most cases, the first line of treatment is the use of a Foley catheter, particularly in cases where benign prostatic hypertrophy or hyperplasia is the cause of the obstruction. However, if obstruction persists, further interventions may be necessary.
In such cases, a Coudé tip Foley catheter may be used, or more significant interventions may be required. Medication therapies may also be considered in certain cases. Alpha-1-adrenergic receptor inhibitors such as terazosin and tamsulosin have been shown to improve symptoms of urinary obstruction in patients with BPH by relaxing the smooth muscles in the bladder and prostate. Studies have indicated that tamsulosin has a positive effect on moderate to severe obstructive symptoms due to BPH, with minimal side effects such as orthostasis.
Additionally, medications like leuprolide and bicalutamide, which act through antiandrogen and luteinizing hormone agonism, respectively, may be helpful in reducing obstruction by shrinking the prostate. Dutasteride and finasteride are approved by the FDA for the treatment of benign prostatic hyperplasia (BPH). These drugs work by inhibiting the 5-alpha-reductase enzyme, which is responsible for the conversion of testosterone to dihydrotestosterone (DHT). By blocking this conversion, they can help reduce the size of the prostate, which is often enlarged in BPH.
In cases of BPH, it is common for medical therapies to be combined in order to produce a more effective outcome. Combining different medications often produces a synergistic effect, which means that the overall effectiveness of the treatment is greater than the sum of its individual components. In cases where BPH has caused obstructive nephropathy, it is important to address the urinary tract obstruction to prevent further kidney damage.
The obstruction can often be relieved through medical or surgical interventions, depending on the severity and underlying cause. Once the obstruction has been relieved, medical therapies such as finasteride and dutasteride may be used to help reduce the size of the prostate and prevent further obstruction.
medtigo
Urinary Tract Obstruction
Updated :
September 4, 2023
Urinary tract obstruction, also known as obstructive uropathy, is a medical condition that affects the urinary system. It results from the blockage of urine flow, which can be caused by structural or functional abnormalities. The blockage leads to the backup of urine in the kidneys. Obstructive uropathy can occur unilaterally or bilaterally, depending on the location of the obstruction.
The symptoms of this condition can vary but typically involve difficulty initiating urination, acute urinary retention, lower abdominal discomfort, and distention. The severity of the symptoms depends on the degree and duration of the obstruction. Urinary tract obstruction can be acute or chronic and affect people of all ages and demographics. The condition can be caused by various factors, including urinary stones, tumors, prostate enlargement, congenital abnormalities, and trauma.
Urinary obstruction can affect individuals of all age groups, but it is most commonly observed in two distinct populations, namely infants and the elderly. While congenital genitourinary tract abnormalities such as posterior urethral valves may cause urinary obstruction in children, they only represent around 4% of all cases.
On the other hand, most cases occur in individuals over 60, with males being more frequently affected due to the presence of the prostate gland, which may undergo benign prostatic hyperplasia or develop cancer. In men, symptoms of urinary retention resulting from BPH may arise in up to 2% of cases per year.
Obstructive uropathy is much less common in females. Nonetheless, other factors, such as pregnancy or childbirth, may increase the risk of urinary obstruction in women.
When there is an obstruction in the urinary tract, urine flow is restricted, causing urine to flow back into the kidney’s collecting system. Over time, this can lead to the expansion of the urinary tract and damage the kidney’s filtration system, resulting in obstructive nephropathy.
This condition can be caused by various factors, including increased pressure due to distention and decreased blood flow. In cases of partial obstruction, the body may attempt to alleviate the obstruction by increasing ureteral peristalsis. However, complete obstruction can lead to increased distention and intraluminal pressures, causing more damage.
Animal studies have shown the involvement of the renin-angiotensin-aldosterone system and increased expression of TGF-beta1 in hydronephrotic kidneys, which may also occur in humans. It is challenging to predict the rate and timing of kidney damage, underscoring the importance of early detection and treatment of the obstruction.
Obstructive uropathy have multiple causes, with benign prostatic hypertrophy or hyperplasia being the most diagnosed. However, other possible causes include prostatic adenocarcinoma, urethral strictures, colonic endometriosis, phimosis or paraphimosis, retroperitoneal adenopathy, urolithiasis, ureterocele, neuropathic bladder dysfunction, bladder endometriosis, parasitic obstructions, and urate nephrolithiasis.
Accurate diagnosis of the underlying cause heavily relies on a thorough history and physical examination. Obstructive uropathy can also manifest during the neonatal period, indicating the need to assess genitourinary tract dilatation and vesicoureteral reflux and emphasize the importance of performing intrauterine fetal anatomy ultrasounds.
The prognosis of an obstruction largely depends on its underlying cause. If the obstruction is acute, it is more likely to be reversible and less harmful to kidney function. However, chronic obstruction can have long-term detrimental effects on renal function.
If only one kidney is affected initially, the likelihood of developing chronic renal problems is lower. Long-term management, such as hemodialysis or renal transplant, may be necessary in rare cases where renal dysfunction persists or worsens after acute obstruction. Neglecting to treat concurrent UTIs can also worsen the overall prognosis.
Clinical History
Urinary tract obstructions can cause a wide range of symptoms. The severity and symptoms depend on various factors, including the location and degree of obstruction and the time since onset. Pain is a common symptom associated with urinary tract obstructions, typically felt in the abdominal and flank region.
When assessing a patient with suspected urinary tract obstruction, healthcare providers may use the characteristics of the pain to help determine the underlying cause and location of the obstruction.
Other symptoms that may suggest a specific underlying cause of urinary tract obstruction include night sweats, unintentional weight loss, and hematuria with a nodular prostate on examination, which may indicate prostatic malignancy. Additionally, previous radiation therapy or other cancer treatments can lead to scarring in the urinary tract, which can also result in obstruction.
Physical Examination
A comprehensive evaluation of the patient’s strength, sensation, reflexes, and muscle tone can provide valuable information for diagnosing urinary tract obstruction. Conducting a thorough medical history and physical examination can help identify the underlying cause of the condition. If a patient experiences symptoms such as nocturia, dysuria, urinary urgency or frequency, and decreased force of the urinary stream, it could be an indication of benign prostatic hyperplasia or prostatic adenocarcinoma.
Additionally, the presence of a fever could be a cause for concern for a concomitant urinary tract infection and, potentially, septicemia. In the case of a nodular prostate on examination, hematuria, and recent unintentional weight loss, it is important to consider the possibility of prostatic malignancy.
Patients experiencing gastrointestinal symptoms such as constipation, nausea, vomiting, and diarrhea could be diagnosed with fecal impaction, bowel obstruction, or a colonic mass, contributing to urinary tract obstruction. Moreover, patients who have had recent surgeries, such as appendectomy or hysterectomy, may have a ureteral injury that should be taken into consideration.
Differential Diagnoses
Nephrolithiasis
Prostatitis
Tuberculosis
Spinal epidural abscess
Correcting electrolyte abnormalities is necessary, and prompt action should be taken to address obstructive uropathy. Bladder volume measurements can aid in determining the appropriate course of treatment. In most cases, the first line of treatment is the use of a Foley catheter, particularly in cases where benign prostatic hypertrophy or hyperplasia is the cause of the obstruction. However, if obstruction persists, further interventions may be necessary.
In such cases, a Coudé tip Foley catheter may be used, or more significant interventions may be required. Medication therapies may also be considered in certain cases. Alpha-1-adrenergic receptor inhibitors such as terazosin and tamsulosin have been shown to improve symptoms of urinary obstruction in patients with BPH by relaxing the smooth muscles in the bladder and prostate. Studies have indicated that tamsulosin has a positive effect on moderate to severe obstructive symptoms due to BPH, with minimal side effects such as orthostasis.
Additionally, medications like leuprolide and bicalutamide, which act through antiandrogen and luteinizing hormone agonism, respectively, may be helpful in reducing obstruction by shrinking the prostate. Dutasteride and finasteride are approved by the FDA for the treatment of benign prostatic hyperplasia (BPH). These drugs work by inhibiting the 5-alpha-reductase enzyme, which is responsible for the conversion of testosterone to dihydrotestosterone (DHT). By blocking this conversion, they can help reduce the size of the prostate, which is often enlarged in BPH.
In cases of BPH, it is common for medical therapies to be combined in order to produce a more effective outcome. Combining different medications often produces a synergistic effect, which means that the overall effectiveness of the treatment is greater than the sum of its individual components. In cases where BPH has caused obstructive nephropathy, it is important to address the urinary tract obstruction to prevent further kidney damage.
The obstruction can often be relieved through medical or surgical interventions, depending on the severity and underlying cause. Once the obstruction has been relieved, medical therapies such as finasteride and dutasteride may be used to help reduce the size of the prostate and prevent further obstruction.
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
